openPR Logo
Press release

Global Checkpoint Inhibitors Market Shares and its growth

12-04-2017 12:50 PM CET | Health & Medicine

Press release from: Market Data Forecast

Global Checkpoint Inhibitors Market Shares and its growth

Global Checkpoint Inhibitors Market was worth USD 6.08 billion in 2016 and is expected to reach USD 21.25 billion by 2021 with a CAGR of 28.4 %.
Checkpoint Inhibitors are drugs used in Immunotherapy. They are generally made up of antibodies that lead an immune system attack on cancer cells. T-cells launches an attack when it detects infected or Cancerous. Immune system uses a series of molecules called checkpoint molecules to protect normal cells from attack. Cancer cells use these Checkpoints to escape T-cells by arraying themselves with Normal Cells. Checkpoint Inhibitors block these proteins on cancer cells which lets T-Cells launch an attack on Cancer cells.

Browse market data tables and in-depth TOC of the Global Checkpoint Inhibitors Industry to 2021 @ http://www.marketdataforecast.com/market-reports/global-checkpoint-inhibitors-market-2177/

Rising Prevalence of cancer globally, and increasing funding and government support towards developing new drugs are some of the factors driving the growth of the market. However, high expense involved in R&D activities is one of the major factors restricting the growth of the market.

Checkpoint Inhibitors Market is segmented based on Drug type and Application. Based on Drug type, market is segmented into PD-1 inhibitors, PD-L1 inhibitors, CTLA-4, Chimeric Antigen Receptor T-cell, others. Based on Application, market is segmented into Lung cancer, Renal cancer, Blood cancer, Bladder Cancer, Hodgkin lymphoma, Melanoma, Others. CTLA-4 Segment holds the highest share accounting for almost 94 % of the overall market. However, this segment is expected to lose some of its market to PD-1 inhibitors segment during the forecast period as majority of new treatments is based on PD-1 inhibitors.

Geographically, market is further segmented into Asia-Pacific, Europe, Latin America, Middle east and Africa and North America. North America dominates the global market owing the relatively high clinical trials and funding available in this region. Asia-Pacific is the fastest growing region because of collaborations of international players with companies in this region.

Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/global-checkpoint-inhibitors-market-2177/request-sample

Some of the key players in the checkpoint inhibitors market are Merck & Co., Inc., Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical Co., Ltd., Juno Therapeutics, Novartis International AG, and Kite Pharma.

Market Segmentation

1) Drug Type
• Introduction
• PD-1 inhibitors
• PD-L1 inhibitors
• CTLA-4
• Chimeric Antigen Receptor T-cell
• Others
• Y-o-Y Growth Analysis, By Drug Type
• Market Attractiveness Analysis, By Drug Type
• Market Share Analysis, By Drug Type

2) Application
• Introduction
• Lung cancer
• Renal cancer
• Blood cancer
• Bladder Cancer
• Hodgkin lymphoma
• Melanoma
• Others
• Y-o-Y Growth Analysis, By Application
• Market Attractiveness Analysis, By Application
• Market Share Analysis, By Application

Inquire before Buying at http://www.marketdataforecast.com/market-reports/global-checkpoint-inhibitors-market-2177/inquire

Reasons to buy Global Checkpoint Inhibitors Market Research Report:
• Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
• Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

For more information, kindly visit, www.marketdataforecast.com

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com

Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.

531/MIG-II, Rd Number 1, Kukatpally Housing Board Colony, Kukatpally, Hyderabad, Telangana 500072
contact@marketdataforecast.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Checkpoint Inhibitors Market Shares and its growth here

News-ID: 843621 • Views:

More Releases from Market Data Forecast

Personalized Nutrition Market is growing at a brisk pace
Personalized Nutrition Market is growing at a brisk pace
The global personalized nutrition market size is expected to be valued at USD 10.84 thousand units in 2024 and reach USD 21.80 thousand units by 2029, growing at a CAGR of 15.0% from 2024 to 2029. Global Personalized Nutrition Market Report Scope: • Market Size (2029): USD 21.80 thousand units • Market Size (2024): USD 10.84 thousand units • CAGR (2024 to 2029): 15% • Base Year: 2023 • Forecast Period: 2024 to 2029 • Segments
Anticipating the Future of the Antibodies Market
Anticipating the Future of the Antibodies Market
The Antibodies market size is expected to be valued at USD 183.7 billion in 2024 and reach USD 183.7 billion by 2029, growing at a CAGR of 11.31% from 2024 to 2029. Antibodies, also known as immunoglobulins, are Y-shaped proteins the immune system produces in response to foreign substances called antigens. Antibodies are employed in various applications, such as diagnostics, research, and therapeutics, which play a crucial role. Global Antibodies Market Report
The Power of Herbal Medicine in Healthcare Market
The Power of Herbal Medicine in Healthcare Market
The herbal medicine market size is expected to be valued at USD 215.4 billion in 2024 and reach USD USD 305.3 billion by 2029, growing at a CAGR of 7.22% from 2024 to 2029. Herbal medicines, derived from plants or plant parts like leaves, flowers, seeds, roots, and stems, have been utilized across diverse cultures for centuries due to their therapeutic properties. They can be prepared in various forms, such as
Innovative Surge Wearable Medical Devices Market Thrives
Innovative Surge Wearable Medical Devices Market Thrives
The global wearable medical devices market size is expected to be valued at USD 11194 million in 2024 and reach USD 28322 million by 2029, growing at a CAGR of 20.40 % from 2024 to 2029. Wearable medical devices are devices that customers can wear, such as activity trackers and smartwatches. These devices are designed to monitor and collect real-time data on customer health and fitness. Global Wearable Medical Devices Market

All 5 Releases


More Releases for Checkpoint

Immune Checkpoint Inhibitors Market: Current Evidence And Future Perspectives Of …
Stratagem Market Insights delivers key insights for the Immune Checkpoint Inhibitors market in its published report, which include global industry analysis, Size, Growth, Opportunities, Emerging Trends, Challenges, and Geographic Regions over the forecast period (2021-2028). In terms of revenue, the global Immune Checkpoint Inhibitors market is projected to grow at a CAGR of XX% during the forecast period, owing to several factors about which SMI offers detailed insights and forecasts
Immune Checkpoint Inhibitor
Immune Checkpoint Inhibitors Market Insights 2019, Global and Chinese Scenario is a professional and indepth study on the current state of the global Immune Checkpoint Inhibitors industry with a focus on the Chinese market. The report provides key statistics on the market status of the Immune Checkpoint Inhibitors manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an
Global Checkpoint Inhibitors Market 2019 Snapshot Analysis Till 2023
Global Checkpoint Inhibitors Market 2019-2023: The treatment of cancer patients involves a multidisciplinary approach encompassing surgery, radiotherapy, and chemotherapy. Traditionally, patients with metastatic disease are treated with combination cytotoxic chemotherapy or targeted agents; although chemotherapy treatment has good response rates complete responses are rarely seen. During the last decade the field of immuno-oncology has rapidly advanced and a number of agents which modulate the immune system are beginning to emerge and
PDF Checkpoint 1.8.5 Improves Color Conversion Handling
Zevrix Solutions announces PDF Checkpoint 1.8.5, a maintenance update to company's PDF preflight and conversion solution. Remarkably fast, PDF Checkpoint automatically preflights, exports as images, splits and optimizes Adobe PDF files. The helps users eliminate costly mistakes and optimize PDF documents for print, web and mobile devices. The new version improves handling of installed ICC profiles which are used to perform conversion of PDF files to different color spaces. Toronto (ON),
PDF Checkpoint Now Can Preflight PDF Document Font Names
Toronto (ON), Canada -- Zevrix Solutions today announces PDF Checkpoint 1.7.19, a feature update to the company's PDF preflight and conversion automation tool (http://www.zevrix.com/PDFCheckpoint.php). Remarkably fast, PDF Checkpoint automatically preflights, exports as images, splits and optimizes multiple PDF documents. PDF Checkpoint is an ideal program for users who need a fast, affordable and easy to use solution to check PDF files for errors and prepare them for print, web and
Immune Checkpoint Inhibitors Market - Global Industry Analysis 2016-2024
The immune system of human body depends on multiple checkpoints or immunological breaks, which avoid over-activation of the healthy cells or immune system. Tumor or cancerous cells often take advantage of these checkpoints to escape detection and fight against immune system. To struggle against such cancer cells, the focus of the scientists and drug developers is gradually diverting towards immunotherapeutics, which makes use of the body’s own immune system or